학술논문
First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial
Document Type
Article
Author
Cytryn, Samuel L; Moy, Ryan H; Cowzer, Darren; Shah, Ronak H; Chou, Joanne F; Joshi, Smita S; Ku, Geoffrey Y; Maron, Steven B; Desai, Avni; Yang, Jessica; Sugarman, Ryan; Rao, Devika; Goldberg, Zoe; Charalambous, Carmelina; Lapshina, Maria; Antoine, Ariel; Socolow, Fiona; Trivedi, Nikhil; Capanu, Marinela; Gerdes, Hans; Schattner, Mark A; Simmons, Marc; Lacouture, Mario E; Paroder, Viktoriya; Tang, Laura H; Shia, Jinru; Ilson, David H; Solit, David B; Berger, Michael F; Janjigian, Yelena Y
Source
In The Lancet Oncology October 2023 24(10):1073-1082
Subject
Language
ISSN
1470-2045